Vanda Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Vanda Pharmaceuticals Ownership

Who owns Vanda Pharmaceuticals?

Vanda Pharmaceuticals is owned by Cycle Pharmaceuticals. It was acquired on October 14, 2024.

Vanda Pharmaceuticals Business Overview

Where is Vanda Pharmaceuticals headquartered?

Vanda Pharmaceuticals is headquartered in Washington, District of Columbia.

What is Vanda Pharmaceuticals’ revenue?

Vanda Pharmaceuticals disclosed revenue of 193M USD for 2023 and 254M USD for 2022.

How many employees does Vanda Pharmaceuticals have?

Vanda Pharmaceuticals has 203 employees.

What sector is Vanda Pharmaceuticals in?

Vanda Pharmaceuticals is a life science company.

When was Vanda Pharmaceuticals founded?

Vanda Pharmaceuticals was founded in 2002.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 175 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 161 by strategics.

Vanda Pharmaceuticals

Vanda Pharmaceuticals, Inc.

2200 Pennsylvania Ave NW Suite 300E,
Washington, District of Columbia 20037
United States,
(202) 734-3400
www.vandapharma.com

Vanda Pharmaceuticals is a bio pharmaceutical company focused on the development and commercialization of innovative therapies. Vanda Pharmaceuticals is based in Washington, District of Columbia.


 Subscribe to unlock this and 207,183
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.